Negative Factors Company Differentiation –In the generic drug industry, limited barriers to entry exist –Prices are market driven and market determined and can eat into profits Litigation Uncertainty –Mylan is currently involved in several legal proceedings that can have substantial effects on profitability –The outcome of the proceedings is relatively uncertain Lack of Proprietary Patents –Mylan has limited prominent proprietary or NDA approvals.